Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
about
Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosisSeeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.The role of regulatory T cells in neurodegenerative diseases.Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.Subacute herpes simplex virus type 1 encephalitis as an initial presentation of chronic lymphocytic leukemia and multiple sclerosis: a case report.
P2860
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@en
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@nl
type
label
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@en
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@nl
prefLabel
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@en
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@nl
P2093
P2860
P356
P1476
Multiple sclerosis: reduced pr ...... o herpes simplex virus type 1.
@en
P2093
P2860
P304
P356
10.1177/1352458508094401
P577
2008-07-24T00:00:00Z